The Global Nebulizer Market, valued at USD 1.16 billion in 2023, is projected to reach USD 2.05 billion by 2032, expanding at a Compound Annual Growth Rate (CAGR) of 6.57% from 2024 to 2032. This growth is fueled by the increasing prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis, alongside growing awareness of effective respiratory care solutions.Nebulizers play a vital role in delivering medications directly to the lungs, making th...
more